M
MDxHealth SA
LSE:0O8G
MDxHealth SA
LSE:0O8G
Price:
3.89
EUR
3.6%
Market Closed
Market Cap:
€168.5k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
MDxHealth SA
LSE:0O8G
|
BE |
|
W
|
Watsco Inc
F:WC3
|
US |
|
C
|
Cooper Companies Inc
SWB:CP6
|
US |
|
P
|
Polytec Holding AG
SWB:P4N
|
AT |
|
G
|
GEN Restaurant Group Inc
NASDAQ:GENK
|
US |
|
Kuaishou Technology
HKEX:1024
|
CN |
|
Cikarang Listrindo Tbk PT
F:B2O
|
ID |
|
BYD Co Ltd
LSE:0VSO
|
CN |
|
Valneva SE
PAR:VLA
|
FR |
|
Azrieli Group Ltd
OTC:AZRGF
|
IL |
|
H
|
Haseko Corp
XBER:HS6
|
JP |
|
L
|
LTC Properties Inc
LSE:0JSP
|
US |
|
B
|
Bureau Veritas SA
SWB:4BV
|
FR |
|
B
|
Bellring Brands Inc
F:D51
|
US |
|
APi Group Corp
NYSE:APG
|
US |
|
G
|
Galapagos NV
LSE:0JXZ
|
BE |
Wall St Price Targets
0O8G Price Targets Summary
MDxHealth SA
MDxHealth SA
Wall Street analysts forecast 0O8G stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 0O8G is 22.33 EUR with a low forecast of 7.63 EUR and a high forecast of 39.64 EUR.
Lowest Forecast
Price Target
7.63
EUR
96% Upside
Average Forecast
Price Target
22.33
EUR
474% Upside
Highest Forecast
Price Target
39.64
EUR
919% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0O8G's stock price target?
Price Target
22.33
EUR
22.33
EUR
According to Wall Street analysts, the average 1-year price target for 0O8G is 22.33 EUR with a low forecast of 7.63 EUR and a high forecast of 39.64 EUR.
What is the Revenue forecast for MDxHealth SA?
Projected CAGR
8%
8%
Over the last 14 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 5 years is 8%.
